Kanta-Häme Central Hospital
14
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
21%
3 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Laparoscopic Approach for Emergency Colon Resection
Role: collaborator
The MOTIVE (Multiparas Overcoming Childbirth Fear Through Intervention and Empowerement) Feasibility Trial
Role: collaborator
Treatment of Children's Forearm Shaft Fractures With Biodegradable Intramedullary Nailing, Compared With Elastic Stable Intramedullary Nailing
Role: collaborator
SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients)
Role: collaborator
SOLIDARITY Finland Plus Long-COVID
Role: collaborator
A Study of Surgical Weight Loss to Treat Obstructive Sleep Apnea
Role: collaborator
The Finnish Faecal Microbiota Transplantation Study (FINFMT)
Role: collaborator
First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02
Role: collaborator
Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT
Role: collaborator
TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis
Role: collaborator
Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis
Role: lead
Hämeenlinna Metabolic Syndrome Research Program: Effects of Rapeseed Oil on Serum Lipids and Platelet Function
Role: lead
Hämeenlinna Metabolic Syndrome Research Program: Oxidized LDL and Arterial Elasticity in Metabolic Syndrome and Controls (HMS-01)
Role: lead
Conservative or Operative Treatment for the Shoulder Impingement Syndrome?
Role: lead
All 14 trials loaded